Scotia Capital’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.1M Buy
182,997
+8,263
+5% +$637K 0.05% 181
2025
Q4
$13.9M Buy
174,734
+9,500
+6% +$749K 0.06% 173
2025
Q3
$12.5M Sell
165,234
-14,676
-8% -$1.01M 0.05% 179
2025
Q2
$12.4M Buy
179,910
+23,462
+15% +$1.54M 0.06% 175
2025
Q1
$10.6M Buy
156,448
+22,751
+17% +$1.36M 0.06% 178
2024
Q4
$6M Sell
133,697
-102,940
-44% -$5.77M 0.03% 234
2024
Q3
$14.9M Buy
236,637
+3,555
+2% +$207K 0.08% 144
2024
Q2
$13.8M Sell
233,082
-226,230
-49% -$14.2M 0.08% 145
2024
Q1
$36.6M Buy
459,312
+9,872
+2% +$754K 0.22% 71
2023
Q4
$35.5M Sell
449,440
-8,389
-2% -$597K 0.23% 72
2023
Q3
$32M Sell
457,829
-1,635
-0.4% -$116K 0.23% 69
2023
Q2
$31.8M Buy
459,464
+10,173
+2% +$724K 0.22% 71
2023
Q1
$33.4M Buy
449,291
+26,434
+6% +$2.22M 0.24% 70
2022
Q4
$39.4M Buy
422,857
+1,682
+0.4% +$162K 0.3% 57
2022
Q3
$40.2M Buy
421,175
+9,711
+2% +$961K 0.32% 57
2022
Q2
$38.1M Buy
411,464
+34,891
+9% +$3.41M 0.28% 61
2022
Q1
$38.1M Sell
376,573
-35,480
-9% -$3.73M 0.24% 65
2021
Q4
$42.5M Sell
412,053
-15,514
-4% -$1.43M 0.28% 63
2021
Q3
$36.3M Buy
427,567
+4,069
+1% +$341K 0.26% 71
2021
Q2
$35.3M Sell
423,498
-13,740
-3% -$1.13M 0.26% 75
2021
Q1
$32.9M Sell
437,238
-87,257
-17% -$6.36M 0.27% 70
2020
Q4
$35.8M Sell
524,495
-12,132
-2% -$789K 0.33% 65
2020
Q3
$31.3M Buy
536,627
+15,724
+3% +$978K 0.34% 62
2020
Q2
$33.9M Sell
520,903
-20,683
-4% -$1.3M 0.47% 47
2020
Q1
$32.1M Buy
541,586
+17,406
+3% +$1.16M 0.45% 48
2019
Q4
$38.9M Buy
524,180
+41,014
+8% +$2.88M 0.43% 50
2019
Q3
$30.5M Buy
483,166
+60,451
+14% +$3.58M 0.36% 55
2019
Q2
$23M Sell
422,715
-32,147
-7% -$1.73M 0.28% 65
2019
Q1
$24.5M Sell
454,862
-15,587
-3% -$962K 0.32% 62
2018
Q4
$30.8M Buy
470,449
+75,508
+19% +$5.64M 0.46% 44
2018
Q3
$31.1M Sell
394,941
-94,710
-19% -$6.77M 0.39% 51
2018
Q2
$30.2M Buy
489,651
+2,820
+0.6% +$186K 0.42% 49
2018
Q1
$30.3M Buy
486,831
+69,038
+17% +$4.95M 0.42% 49
2017
Q4
$30.3M Sell
417,793
-71,260
-15% -$5.18M 0.4% 51
2017
Q3
$39.8M Buy
489,053
+64,298
+15% +$5.09M 0.57% 42
2017
Q2
$34.2M Sell
424,755
-6,535
-2% -$516K 0.58% 39
2017
Q1
$33.9M Sell
431,290
-47,257
-10% -$3.77M 0.58% 38
2016
Q4
$37.8M Sell
478,547
-24,830
-5% -$2.01M 0.6% 34
2016
Q3
$44.9M Buy
503,377
+103,746
+26% +$9.79M 0.82% 27
2016
Q2
$38.3M Buy
399,631
+46,147
+13% +$4.6M 0.78% 29
2016
Q1
$36.7M Buy
353,484
+109,280
+45% +$10.6M 0.8% 28
2015
Q4
$23.2M Buy
244,204
+9,400
+4% +$921K 0.53% 40
2015
Q3
$22.6M Buy
234,804
+35,435
+18% +$3.73M 0.51% 36
2015
Q2
$20.8M Buy
199,369
+35,770
+22% +$3.65M 0.42% 49
2015
Q1
$16.9M Buy
163,599
+19,560
+14% +$1.98M 0.44% 48
2014
Q4
$13.9M Buy
144,039
+17,090
+13% +$1.51M 0.36% 55
2014
Q3
$10.1M Sell
126,949
-2,726
-2% -$215K 0.22% 74
2014
Q2
$9.77M Buy
129,675
+11,469
+10% +$867K 0.21% 77
2014
Q1
$8.85M Buy
118,206
+47,558
+67% +$3.36M 0.2% 77
2013
Q4
$5.06M Buy
70,648
+37,438
+113% +$2.41M 0.12% 109
2013
Q3
$1.89M Buy
33,210
+29,077
+704% +$1.73M 0.05% 185
2013
Q2
$236K Buy
+4,133
New +$239K 0.01% 405

Other funds holding CVS

Scotia Capital's CVS Position: Q1 2026 in Review

Scotia Capital increased its CVS Health (CVS) stake by 4.7% in Q1 2026, buying an estimated $637K and bringing the position to 182,997 shares worth $13.1M. The position accounts for 0.05% of the portfolio, ranked #181.

Scotia Capital first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $44.9M in Q3 2016. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Scotia Capital held 182,997 shares of CVS Health worth $13.1M as of Q1 2026.
  • Scotia Capital bought 8,263 CVS Health shares in Q1 2026, an estimated $637K.
  • CVS Health made up 0.05% of Scotia Capital's portfolio in Q1 2026, its #181 holding.
  • Scotia Capital first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Scotia Capital's CVS Health position peaked at $44.9M in Q3 2016.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.